Disease Education Website for Agios Pharmaceuticals

In conjunction with Agios’ unbranded disease education campaign, focused on helping healthcare professionals to identify isocitrate dehydrogenase (IDH) mutations in patients, Viscira was challenged to redesign and relaunch the Agios disease education website known as

The goals of the disease education campaign were as follows:

  1. To raise awareness among healthcare professionals of the relevance of IDH mutations in patients with hematologic malignancies and solid tumors, with a specific focus on patients diagnosed with acute myeloid leukemia (AML).
  2. To motivate healthcare professionals to test their patients for IDH mutations and to help them find an appropriate clinical trial.

In addition to the above goals, the specific goal related to the website relaunch was to:

  1. Identify the most effective user experience to begin to position as the go-to disease education site for IDH in AML and solid tumors in a rapidly evolving therapeutic space.

Click here to read full article in PDF format.